- Areas of Interest
- Techniques
- Systems
- Products & Services
- Informatics
- Science & Education
- Company
- Support
Researchers are harnessing the power of array and NGS technologies to conduct large-scale, global genetic analyses of complex diseases. This high-throughput genomic research is focused on multifactorial genetic discovery of markers related to disease risk. These studies look for changes in structural variation, single nucleotide polymorphisms (SNPs), indels, splice variants, methylation markers.
High-throughput genomic studies with tens to hundreds of thousands of samples require fast, cost-effective array and sequencing tools. Illumina offers array and NGS technologies with unprecedented sample-to-analysis solutions and unparalleled collaborative expertise to meet these needs.
Learn how the HUNT Biobank used Illumina high-throughput arrays to identify a gene that protects against heart attacks.
Read Interview
This dual-flow cell sequencing system delivers the highest throughput and lowest price per sample across multiple applications.
Learn MoreScalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.
Learn MoreFor labs preparing large quantities of NGS libraries, liquid-handling robots and other automation solutions provide a good option.
Learn MoreIllumina Advantage large-scale sequencing products offer the highest level of service and support to ensure operational success for clinical research laboratories.
Learn MoreBaseSpace Cohort Analyzer and BaseSpace Correlation Engine provide robust, secure, and scalable platforms to aggregate and interpret large-scale genomic data for population sequencing applications.
Learn MoreFind arrays that make cost-effective, large-scale genotyping studies possible.
Learn More
Dr Carl Anderson discusses integrated genomic research approaches in inflammatory bowel disease (IBD) research.
High-throughput genomics enables insights about genes and biological pathways associated with diseases like Alzheimer's and Parkinson's.
Tuuli Lappalainen, PhD is working toward identifying how genetic differences may affect an individual's risk for certain diseases.
Jay Veldink, PhD shares how integrative genomics helped drive his ALS research, leading to the discovery that NEK1 is an ALS gene.
Genomics leaders share their perspective on the impact of high-throughput and population sequencing in clinical research.
The Chan Zuckerberg Biohub uses the NovaSeq System to conduct innovative experiments in genomics.
Targeted resequencing is enabling a systematic high-throughput approach to identify rare mosaic mutations in brain malformations.
Amanda Myers, PhD uses a combination of genomics, transcriptomics, and proteomics to explain the complexity of Alzheimer’s disease.